Yangling Metron New Material Co Ltd (300861.SZ) stock: key figures, P/E, revenue and dividend
Industrials · Industrial Machinery & Supplies & Components · China · ISIN CNE100004751
Yangling Metron New Material Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.27 bn CNY | 2.16 bn CNY |
| Gross profit | 303.66 m CNY | 506.31 m CNY |
| Operating income | 179.46 m CNY | 389.00 m CNY |
| EBIT | 178.72 m CNY | 284.11 m CNY |
| Net income | 145.52 m CNY | 243.89 m CNY |
| Diluted EPS – continuing operations | 0.22 CNY | 0.36 CNY |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Yangling Metron New Material Co Ltd
Yangling Metron New Material Inc. researches, develops, manufactures, and sells electroplated diamond wires and other superhard diamond tools in China and internationally. The company is also involved in the research and development of tungsten wire busbar. Its diamond wires are used in various applications, including photovoltaic industry single crystal and polycrystalline silicon slicing, sapphire, magnetic materials, ceramics, crystals, and other high-value hard brittle materials for cutting. The company was incorporated in 2015 and is based in Yangling, China.
More stocks
- OliX PharmaceuticalsInc (226950.KQ)
- TRUPANION, INC. (TRUP)
- Kunshan Huguang Auto Harness Co Ltd (605333.SS)
- Nh Special Purpose Acquisition 14 Co. Ltd (319400.KQ)
- Jinan Acetate Chemical Co Ltd (4763.TW)
- UPBOUND GROUP, INC. (UPBD)
- Hualan Biological Bacterin Inc. (301207.SZ)
- Lyntris Inc. (LYNX)
- Riskified Ltd (RSKD)
- Adient plc (ADNT)
- Shift Up Corporation (462870.KS)
- Damora Therapeutics, Inc. (DMRA)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.